Novartis blood Dx kits to hit Africa through Israeli distributor

By Mark Hollmer Novartis ($NVS) is aligning with an Israeli diagnostics and laboratory equipment company to distribute blood test diagnostic kits in 16 African countries. The deal ...

Given Imaging grabs SmartPill Corp. for $6M

CEO Homi Shamir tells FierceMedicalDevices that the company is looking for other acquisitions By Mark Hollmer Israel’s Given Imaging ($GIVN) has snatched up its first acquisition ...

Much-hyped renal denervation devices could help diabetics, too

By Damian Garde Renal denervation devices, designed to treat hypertension, are already tabbed for big sales in that sphere–$2.8 billion by 2020, analysts say. Now, new research ...

Boston Sci, University of Minnesota forge long-term research deal

By Mark Hollmer Boston Scientific ($BSX) sealed a new, wide-ranging research agreement with the University of Minnesota, underscoring the increased importance of academia to device ...

Illnesses Fuel Scrutiny of Pharmacies

By JONATHAN D. ROCKOFF A meningitis outbreak that has now killed five patients and sickened 35 is focusing renewed attention on the little-regulated world of drug-mixing pharmacies, ...

Missing Data May Skew Clinical Trials

Expert panel recommends steps to prevent or account for incomplete information By Serena Gordon HealthDay Reporter (HealthDay News) — Data missing from clinical trials can undermine ...

Sigma-Tau Pharmaceuticals wins FDA approval for eye treatment

Washington Business Journal by Bill Flook, Staff Reporter Gaithersburg-based Sigma-Tau Pharmaceuticals Inc. said Thursday it has won Food and Drug Administrationapproval for Cystaran, ...

UPDATE 1-U.S. FDA cracks down on websites selling bad drugs

Oct 4 (Reuters) – The U.S. Food and Drug Administration said it has cracked down on thousands of online pharmacies for selling potentially unsafe, unapproved or fake medicines, ...

Defective generic pill revives quality concerns

By Matthew Perrone WASHINGTON (AP) — More Americans than ever are taking generic drugs, as blockbuster medicines like Plavix and Lipitor become available in low-cost versions. But ...

Johnson & Johnson settles five Risperdal suits

By David Sell, Inquirer Staff Writer The former commissioner of the U.S. Food and Drug Administration, David Kessler, says Johnson & Johnson and its Janssen subsidiary broke the ...

Watchdog Seeks Warnings On Blood Pressure Meds

By Ed Silverman Citring safety issues with three classes of widely used blood pressure medications, a consumer watchdog has filed a citizen’s petition asking the FDA to add so-called ...

Former FDA Commish Slams J&J Over Risperdal

By Ed Silverman In the latest setback to Johnson & Johnson and its seemingly futile attempts to defend its Risperdal marketing, the health care giant is attempting to prevent ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS